Diabetes Self-Management Blog

Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company, makers of Tradjenta (linagliptin) and Jentadueto (linagliptin/metformin hydrochloride) tablets, recently announced the debut of My Well Planner, a free online program for adults who have Type 2 diabetes.

The program is designed to help people overcome the emotional barriers they face dealing with diabetes by offering personalized content that adjusts as participants use the tool over time. After enrolling, users are asked to complete a self-assessment that determines their motivation levels; information from this evaluation is then used to tailor the content the individual receives. The program additionally provides progress reports that can be printed out and discussed with a health-care provider.

For more information about My Well Planner, and to register, click here.

This blog entry was written by Web Editor Diane Fennell.

POST A COMMENT       
  

We are currently experiencing technical difficulties with our commenting system. Thank you for your patience as we work to resolve them.


What We're Reading
JDRF 2015 Children's Congress (11/17/14)
Diabetes Self-Management Readers' Poll: Support Groups (11/20/14)
Diabetes Self-Management Readers’ Poll: Daylight Saving Time (11/10/14)
World Diabetes Day (11/14/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.